Related Experiment Video
Updated: Sep 15, 2025

09:53
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
3.7K
Meningiomas Following the Previous Cancer Therapies: Brief Report
N K Venkataramana1, Mahendra Madesh2, Bharggavi Venkat3
1Neurosurgery, Founder Chairman and Director - Neurosciences, Bangalore, Karnataka, India.
Neurology India
|July 13, 2025
Summary
Childhood cancer treatments, including ionizing radiation and chemotherapy, may increase the risk of developing secondary brain tumors like meningiomas later in life. Long-term patient follow-up is crucial for early detection and management.
Area of Science:
- Neuro-oncology
- Radiation oncology
- Pediatric oncology
Background:
- Ionizing radiation and chemotherapy are known to induce secondary brain tumors, including meningiomas and gliomas.
- The literature on treatment-induced tumorigenesis is sparse, with limited understanding of underlying mechanisms.
- Recent molecular studies offer new insights into the pathogenesis of radiation-induced meningiomas.
Purpose of the Study:
- To highlight recent updates in the understanding of brain tumor development following cancer treatment.
- To present cases of meningioma development in patients treated for childhood malignancies.
- To emphasize the need for long-term follow-up in survivors of childhood cancer.
Main Methods:
- Case report of two patients treated for childhood malignancy.
- Review of current literature on radiation- and chemotherapy-induced brain tumors.
- Discussion of emerging molecular and genetic insights into meningioma pathogenesis.
Main Results:
- Two patients developed meningiomas years after childhood cancer treatment.
- Surgical removal of meningiomas resulted in favorable clinical outcomes.
- The molecular and genetic basis for radiation-induced meningiomas is increasingly understood.
Conclusions:
- Cancer survivors, particularly those treated in childhood, may be at increased risk for secondary meningiomas.
- Long-term surveillance is essential for early detection and management of these secondary tumors.
- Understanding the biomolecular pathogenesis is critical for effective clinical management and risk stratification.

